Antifungal Drug May Increase Miscarriage Risk

Pregnant women who take an antifungal medication used to treat vaginal yeast infections are at a higher risk of having a miscarriage compared to women not taking the drug.

Although the increased risk was only slightly higher, a new study is the second one to show a link between oral fluconazole and miscarriage. In a 2016 study, women who used the oral version of fluconazole had a slightly higher risk of miscarriage than those who used the topical version.

Researchers looked at the medical records of 320,000 pregnant women in Quebec. Women who took oral fluconazole had a miscarriage rate of 12% compared to 6% for women who never took the drug, according to findings published in the Canadian Medical Association Journal. Women who took fluconazole had an increased miscarriage risk whether they took the low-dose or high-dose pill.

In a commentary to the study, Drs. Vanessa Paquette and Chelsea Elwood, both of the British Columbia Women’s Hospital and Health Centre, wrote: “The study re-emphasises safe prescribing practices in pregnancy, which include confirming the correct diagnosis and then choosing the safest medication with the largest body of data in pregnancy at the lowest appropriate doses.”


Did you find this article helpful?


Latest News

News Scan: Warfarin, A-Fib, Lavender Oil and Dopamine Agonist Medicine

News Scan: Warfarin, A-Fib, Lavender Oil and Dopamine Agonist Medicine

Every so often a lay person like me slaps her forehead and says out loud, “what took so long?” A veggie works better than a medicine, why not use the veggie? Talking to patients in their home leads to better understanding by the patients? Of course. And less intuitive but…

News Scan 9/4/2019: Breast Cancer, Osteoporosis and Cardio Health

News Scan 9/4/2019: Breast Cancer, Osteoporosis and Cardio Health

Less medicine and a little less food are the themes for keeping healthy this week.  Be well.    Breast Cancer and Hormone Treatment In a large study of published studies (meta analysis) that included more than 100,000 women, those who reported ever using MHT had a 26% higher relative risk…